Marksans Pharma Ltd

NSE: MARKSANS · BSE: 524404 · Pharmaceuticals & Biotechnology · 10 announcements

Share price: ₹336.95
Market cap: ₹15,269 Cr
Revenue (annual): ₹2,951 Cr
Net profit (annual): ₹417.9 Cr
P/E (TTM): 29.6×Sector 50.4×
Promoter holding: 43.87%+0.00% QoQ
FII holding: 17.47%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Promoter Selling (Off-Market) 1 Other Announcement 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

17 Sep 2026 14:12 IST BSE

Promoter Selling (Off-Market)

Marksans Pharma Promoter Selling (Off-Market)

Director Sandra Saldanha gifted 2,28,273 shares of Marksans Pharma Ltd to her daughters in an off-market transaction. This internal transfer reallocates promoter-group equity holdings.

Read the filing ↗

17 Sep 2026 14:20 IST BSE

Other Announcement

Marksans Pharma Other Announcement

Marksans Pharma intimated shareholders about SEBI's extended special window (Feb 2026–Feb 2027) for re-lodgement of pre-April-2019 physical share transfer deeds. No new business, capital, or operational event is disclosed.

Read the filing ↗